Deloitte Survey: Life Sciences Confidence Rises at Company Level, Despite External Considerations
Executives report they are prioritizing growth discipline, AI value proof and resilience in the second half of 2026 NEW YORK, June 25, 2026 /PRNewswire/ -- Life sciences executives report they are demonstrating strong confidence in their own company performance and remain focused on...
Executives report they are prioritizing growth discipline, AI value proof and resilience in the second half of 2026 NEW YORK, June 25, 2026 /PRNewswire/ -- Life sciences executives report they are demonstrating strong confidence in their own company performance and remain focused on...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.